Dr Dr Steve Burnell

Australia’s ADHD system made him ‘snap’. Now he’s raised millions to build a new one

Zac Altman’s ADHD telehealth startup Kantoko has secured $3.5 million in a Side Stage Ventures-led seed round, with Andrew Forrest’s Tenmile and Go1’s founders investing; the article also recalls his earlier ventures’ sales.

Also Dealroom·Startup Daily·Business News Australia·SmartCompany

Superseeder: psychedelic biotech Psylo plants $12 million in latest 'Seed' round

Psylo, a Sydney maker of psychedelic therapies, has landed a US$8 million seed round led by Tenmile while moving to the US; earlier raises in 2022 and 2021 are recalled.

Andrew Forrest backs Sydney biotech startup in $26 million raise

Sydney diagnostics developer SpeeDx banked $26 million for American expansion, with $5 million from Andrew Forrest's new fund Tenmile and follow-on support from Platinum and Northpond.

Also SmartCompany

Billionaires Andrew and Nicola Forrest take aim at peanut allergy

Biotech Aravax has received a US$20 million Series B commitment from Brandon Capital and Tenmile to advance its peanut allergy therapy PVX108 into Phase 2 trials.

Also Brandon Capital portfolio·Startup Daily·Startup News (WA)·Techboard·Startup Daily

Aravax commences Phase 2 development for peanut allergy therapy with $20m commitment to Series B round from Brandon Capital and Tenmile

Aravax has begun its Series B with a US$20 million investment from Brandon Capital and Tenmile, funding Phase 2 trials of its peanut allergy immunotherapy PVX108 while it seeks further capital.

Also Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Forbes Australia·Techboard·Business News Australia

Twiggy Forrest is backing biotech with a new $250 million VC fund

Andrew Forrest's private investment company Tattarang is launching Tenmile, a Perth-based $250 million health-tech venture fund that has already backed Emyria and Carina Biotech and partnered with Rock Health.